26.09.2022 • News

Celanese Makes Concessions on DuPont Acquisition

Celanese has offered concessions to EU regulators to allay concerns about its proposed $11 billion acquisition of DuPont’s Mobility and Materials business, according to Reuters.

The US chemicals company filed its proposed remedies with the European Commission on Sep. 20 — the filing did not disclose the details. The Commission is seeking feedback from rival producers and customers before deciding by Oct. 11 whether to accept Celanese’s proposals, or make further demands.

If the Commission has serious concerns about the deal, it might open an investigation that could take four months to complete.

Photo

The transaction – announced in February and originally expected to close around the end of this year – would be DuPont’s biggest since splitting from DowDuPont in June 2019. DuPont is reshaping its portfolio as a “premier multi-industrial company” serving the automotive, consumer and industrial markets.

Author: Elaine Burridge, Freelance Journalist

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.